With 160 deals in total so far, this year is on track to be a record year for Healthtech. Private Equity activity in the market, which has been steadily increasing over the last 10 years, made up 33% of all deals this quarter. 

Despite the increased number of deals in H1, disclosed M&A deal value accounted for $16.8B in total. 

 

At the the mid-year mark, The Carlyle Group and Constellation still lead the pack of Healthtech acquirers, scoring 4 acquisitions each, Followed by 6 PE firms, such as Clearlake Capital, Riverside and TPG with 3 acquisitions each, Battery, Providence Equity Partners and Bain Capital are close behind with 2 deals each, as well as 2 Strategics HealthCatalyst and VitalHub with 2 deals each too.